Literature DB >> 22302639

Acute Treatment Options for Spinal Cord Injury.

Manjunath Markandaya1, Deborah M Stein, Jay Menaker.   

Abstract

OPINION STATEMENT: Most treatment options for acute traumatic spinal cord injury (SCI) are directed at minimizing progression of the initial injury and preventing secondary injury. Failure to adhere to certain guiding principles can be detrimental to the long-term neurologic and functional outcome of these patients. Therapy for the hyperacute phase of traumatic SCI focuses on stabilizing vital signs and follows the Advanced Trauma Life Support (ATLS) algorithm for ensuring stability of airway, breathing and circulation, and disability (neurologic evaluation)-with spinal stabilization-and exposure. Spinal stabilization, with cervical collars and long backboards, is used to prevent movement of a potentially unstable spinal column injury to prevent further injury to the spinal cord and nerve roots, especially during prehospital transport. Surgery to stabilize the spine is undertaken after life-threatening injuries (hemorrhage, evacuation of intracranial hemorrhage, acute vascular compromise) are addressed. Intensive care unit (ICU) admission is to be considered for all patients with high SCI or hemodynamic instability, as well as those with other injuries that independently warrant ICU admission. Avoidance of hypotension and hypoxia may minimize secondary neurologic injury. Elevating the mean arterial pressure above 85 mmHg for 7 days should be considered, to allow for spinal cord perfusion. The use of intravenous steroids (methylprednisolone) is controversial. Early tracheostomy in patients with lesions above C5 may reduce the number of ventilator days and the incidence of ventilator-associated pneumonia. Select patients may benefit from the placement of a diaphragmatic pacer. Aggressive measures, including CoughAssist and Intermittent Positive Pressure Breaths (IPPB), should be used to maintain lung recruitment and aid in the mobilization of secretions. Some patients with high SCI who are dependent on mechanical ventilation can eventually be liberated from the ventilator with consistent efforts from both the patient and the caregiver, along with some patience. Intermittent catheterization by the patient or a caregiver may be associated with a lower incidence of urinary tract infections, compared with an in-dwelling urinary catheter. Early mobilization of patients and a multidisciplinary approach (including respiratory therapists, nutritional experts, physical therapists, and occupational therapists) can streamline care and may improve long-term outcomes. A number of investigational drugs and therapies offer hope of neurologic recovery for some patients.

Entities:  

Year:  2012        PMID: 22302639     DOI: 10.1007/s11940-011-0162-5

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  18 in total

1.  Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study.

Authors:  M B Bracken; M J Shepard; W F Collins; T R Holford; D S Baskin; H M Eisenberg; E Flamm; L Leo-Summers; J C Maroon; L F Marshall
Journal:  J Neurosurg       Date:  1992-01       Impact factor: 5.115

2.  Effect of epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing, and assisted stepping after motor complete paraplegia: a case study.

Authors:  Susan Harkema; Yury Gerasimenko; Jonathan Hodes; Joel Burdick; Claudia Angeli; Yangsheng Chen; Christie Ferreira; Andrea Willhite; Enrico Rejc; Robert G Grossman; V Reggie Edgerton
Journal:  Lancet       Date:  2011-05-19       Impact factor: 79.321

3.  Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study.

Authors:  M B Bracken; M J Shepard; T R Holford; L Leo-Summers; E F Aldrich; M Fazl; M Fehlings; D L Herr; P W Hitchon; L F Marshall; R P Nockels; V Pascale; P L Perot; J Piepmeier; V K Sonntag; F Wagner; J E Wilberger; H R Winn; W Young
Journal:  JAMA       Date:  1997-05-28       Impact factor: 56.272

4.  Risk factors for organ dysfunction and failure in patients with acute traumatic cervical spinal cord injury.

Authors:  Deborah M Stein; Jay Menaker; Karen McQuillan; Christopher Handley; Bizhan Aarabi; Thomas M Scalea
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

5.  Causes and costs of spinal cord injury in the United States.

Authors:  M J DeVivo
Journal:  Spinal Cord       Date:  1997-12       Impact factor: 2.772

Review 6.  Phrenic nerve stimulation in patients with spinal cord injury.

Authors:  Anthony F DiMarco
Journal:  Respir Physiol Neurobiol       Date:  2009-09-26       Impact factor: 1.931

7.  Prophylactic inferior vena cava (IVC) filter placement may increase the relative risk of deep venous thrombosis after acute spinal cord injury.

Authors:  Peter H Gorman; Syed F A Qadri; Anuradha Rao-Patel
Journal:  J Trauma       Date:  2009-03

8.  Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  William H Geerts; David Bergqvist; Graham F Pineo; John A Heit; Charles M Samama; Michael R Lassen; Clifford W Colwell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

Review 9.  Effect of spinal cord injury on the respiratory system: basic research and current clinical treatment options.

Authors:  M Beth Zimmer; Kwaku Nantwi; Harry G Goshgarian
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

10.  Prevention of venous thromboembolism in the acute treatment phase after spinal cord injury: a randomized, multicenter trial comparing low-dose heparin plus intermittent pneumatic compression with enoxaparin.

Authors: 
Journal:  J Trauma       Date:  2003-06
View more
  13 in total

1.  Effects of different etomidate doses on intraoperative somatosensory-evoked potential monitoring.

Authors:  X-L Meng; L-W Wang; W Zhao; X-Y Guo
Journal:  Ir J Med Sci       Date:  2014-07-25       Impact factor: 1.568

2.  Vascular diseases of the spinal cord: a review.

Authors:  Mirjam Rachel Heldner; Marcel Arnold; Krassen Nedeltchev; Jan Gralla; Jürgen Beck; Urs Fischer
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

3.  Transplantation of Cerebral Dopamine Neurotrophic Factor Transducted BMSCs in Contusion Spinal Cord Injury of Rats: Promotion of Nerve Regeneration by Alleviating Neuroinflammation.

Authors:  Hua Zhao; Lei Cheng; Xinwen Du; Yong Hou; Yi Liu; Zhaoqiang Cui; Lin Nie
Journal:  Mol Neurobiol       Date:  2014-11-25       Impact factor: 5.590

Review 4.  Molecular approaches for spinal cord injury treatment.

Authors:  Fernanda Martins de Almeida; Suelen Adriani Marques; Anne Caroline Rodrigues Dos Santos; Caio Andrade Prins; Fellipe Soares Dos Santos Cardoso; Luiza Dos Santos Heringer; Henrique Rocha Mendonça; Ana Maria Blanco Martinez
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

5.  Percutaneous pedicle screw fixation in polytrauma patients.

Authors:  L Scaramuzzo; F C Tamburrelli; E Piervincenzi; V Raggi; S Cicconi; L Proietti
Journal:  Eur Spine J       Date:  2013-09-17       Impact factor: 3.134

6.  Nontraumatic spinal cord injury at the neurological intensive care unit: spectrum, causes of admission and predictors of mortality.

Authors:  Lukas Grassner; Julia Marschallinger; Martin W Dünser; Helmut F Novak; Alexander Zerbs; Ludwig Aigner; Eugen Trinka; Johann Sellner
Journal:  Ther Adv Neurol Disord       Date:  2015-12-11       Impact factor: 6.570

Review 7.  Serine Proteases and Chemokines in Neurotrauma: New Targets for Immune Modulating Therapeutics in Spinal Cord Injury.

Authors:  Roxana N Beladi; Kyle S Varkoly; Lauren Schutz; Liqiang Zhang; Jordan R Yaron; Qiuyun Guo; Michelle Burgin; Ian Hogue; Wesley Tierney; Wojciech Dobrowski; Alexandra R Lucas
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

8.  Local Serpin Treatment via Chitosan-Collagen Hydrogel after Spinal Cord Injury Reduces Tissue Damage and Improves Neurologic Function.

Authors:  Jacek M Kwiecien; Liqiang Zhang; Jordan R Yaron; Lauren N Schutz; Christian J Kwiecien-Delaney; Enkidia A Awo; Michelle Burgin; Wojciech Dabrowski; Alexandra R Lucas
Journal:  J Clin Med       Date:  2020-04-23       Impact factor: 4.241

9.  Neuroprotective effects of different modalities of acupuncture on traumatic spinal cord injury in rats.

Authors:  Song-He Jiang; Wen-Zhan Tu; En-Miao Zou; Jie Hu; Sai Wang; Jiang-Ru Li; Wan-Sheng Wang; Rong He; Rui-Dong Cheng; Wei-Jing Liao
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-03       Impact factor: 2.629

10.  Elevated Serum Insulin-Like Growth Factor 1 Levels in Patients with Neurological Remission after Traumatic Spinal Cord Injury.

Authors:  Arash Moghaddam; André Sperl; Raban Heller; Kevin Kunzmann; Viola Graeser; Michael Akbar; Hans Jürgen Gerner; Bahram Biglari
Journal:  PLoS One       Date:  2016-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.